Clinical Trials Logo

Hypoparathyroidism clinical trials

View clinical trials related to Hypoparathyroidism.

Filter by:
  • Available  
  • Page 1

NCT ID: NCT05654701 Available - Hypoparathyroidism Clinical Trials

Expanded Access Program of Palopegteriparatide in Patients With Hypoparathyroidism

Start date: n/a
Phase:
Study type: Expanded Access

To provide palopegteriparatide (TransCon PTH), an investigational parathyroid hormone (PTH) replacement therapy in an expanded access setting for adult patients with hypoparathyroidism who have previously received PTH-treatment, who meet the eligibility criteria for this protocol as described below and have a clear unmet medical need that cannot be adequately treated by a commercial product or a clinical trial.